Article

Genetic analysis of the early natural history of epithelial ovarian carcinoma.

Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
PLoS ONE (Impact Factor: 3.53). 04/2010; 5(4):e10358. DOI: 10.1371/journal.pone.0010358
Source: PubMed

ABSTRACT The high mortality rate associated with epithelial ovarian carcinoma (EOC) reflects diagnosis commonly at an advanced stage, but improved early detection is hindered by uncertainty as to the histologic origin and early natural history of this malignancy.
Here we report combined molecular genetic and morphologic analyses of normal human ovarian tissues and early stage cancers, from both BRCA mutation carriers and the general population, indicating that EOCs frequently arise from dysplastic precursor lesions within epithelial inclusion cysts. In pathologically normal ovaries, molecular evidence of oncogenic stress was observed specifically within epithelial inclusion cysts. To further explore potential very early events in ovarian tumorigenesis, ovarian tissues from women not known to be at high risk for ovarian cancer were subjected to laser catapult microdissection and gene expression profiling. These studies revealed a quasi-neoplastic expression signature in benign ovarian cystic inclusion epithelium compared to surface epithelium, specifically with respect to genes affecting signal transduction, cell cycle control, and mitotic spindle formation. Consistent with this gene expression profile, a significantly higher cell proliferation index (increased cell proliferation and decreased apoptosis) was observed in histopathologically normal ovarian cystic compared to surface epithelium. Furthermore, aneuploidy was frequently identified in normal ovarian cystic epithelium but not in surface epithelium.
Together, these data indicate that EOC frequently arises in ovarian cystic inclusions, is preceded by an identifiable dysplastic precursor lesion, and that increased cell proliferation, decreased apoptosis, and aneuploidy are likely to represent very early aberrations in ovarian tumorigenesis.

0 Followers
 · 
110 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Targeted prevention of ovarian cancer is hindered by the inaccessibility of ovarian tissue, lack of accepted biomarkers and low disease incidence. However, ovarian cancer has common risk factors and shared etiologies with breast cancer. Chemoprevention of ovarian cancer has been demonstrated incidentally during testing of novel breast cancer prevention drugs. Here it is hypothesized that the development of combined ovarian and breast cancer prevention strategies is a preferable strategy for ovarian cancer prevention.
    Medical Hypotheses 08/2012; 79(4):549-51. DOI:10.1016/j.mehy.2012.07.018 · 1.15 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The lack of significant progress in treating epithelial ovarian cancer (EOC) underscores the need to gain a better understanding of the processes that lead to chemoresistance and recurrence. The cancer stem cell hypothesis offers an attractive explanation of how subpopulations of cells within a patient's tumour might remain refractory to treatment and subsequently form the basis of recurrent chemoresistant disease. This review will examine the literature defining somatic stem cells of the ovary and fallopian tube, two tissues which give rise to EOC. In addition, considerable research will be reviewed that has identified subpopulations of EOC cells, based on marker expression (CD133, CD44, CD117, CD24, EPCAM, LY6A, ALDH1 and side population), which are enriched for tumour initiating cells (TIC). While many studies identified either CD133 or CD44 as markers useful for enriching for TICs, there is little consensus. This suggests that EOC cells may have a phenotypic plasticity that may preclude the identification of universal markers defining a cancer stem cell. The assay which forms the basis of quantifying TICs is the xenograft assay. Considerable controversy surrounds the xenograft assay and it is essential that some of the potential limitations be examined in this review. Highlighting such limitations or weaknesses is required to properly evaluate data and broaden our interpretation of potential mechanisms that might be contributing to the pathogenesis of ovarian cancer.
    Reproduction (Cambridge, England) 10/2014; DOI:10.1530/REP-14-0234 · 3.26 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Gene annotation databases (compendiums maintained by the scientific community that describe the biological functions performed by individual genes) are commonly used to evaluate the functional properties of experimentally derived gene sets. Overlap statistics, such as Fishers Exact test (FET), are often employed to assess these associations, but don't account for non-uniformity in the number of genes annotated to individual functions or the number of functions associated with individual genes. We find FET is strongly biased toward over-estimating overlap significance if a gene set has an unusually high number of annotations. To correct for these biases, we develop Annotation Enrichment Analysis (AEA), which properly accounts for the non-uniformity of annotations. We show that AEA is able to identify biologically meaningful functional enrichments that are obscured by numerous false-positive enrichment scores in FET, and we therefore suggest it be used to more accurately assess the biological properties of gene sets.
    Scientific Reports 02/2014; 4:4191. DOI:10.1038/srep04191 · 5.08 Impact Factor

Preview (2 Sources)

Download
3 Downloads
Available from